Immunotherapy Biotech Poised to Soar – Minyanville.com
|
Immunotherapy Biotech Poised to Soar
Minyanville.com While immunotherapy is an exciting area for investing, the blue-chip biopharmaceutical companies are mega-caps with only limited room for growth. They're rushing into immunotherapy to fend off the revenue cliff they face when patents for their … |
